CME Listings
Evaluating the Efficacy of Disease Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
The France Foundation
0.25
AMA PRA Category 1
Podcast Lecture
Free
10/31/2016
Listen to expert review of recent articles and review clinical applications of the findings.
After completing the course, participants will be able to:
- Differentiate between non-platform (newer) MS therapies, which can be considered when starting or switching treatment
- Examine criteria to determine whether to initiative or switch treatment